Skip to main content
TM

TJELLESEN MAX JENNE A/S

aktiv
CVR 79091812AktieselskabOle Lippmanns Vej 2, 2630 TaastrupEngroshandel med medicinalvarer og sygeplejeartikler
Latest accounts
2026
Statement scope
Standalone
Verified
05 Nov 2026
Sources
5

What changed?

Source-backed changes, not an assessment.

2026
Source note

Source access required

CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.

1 source

Key figures

Latest period: 2026

Revenue

DKK 4.4bn

Revenue growth: 7.6%

Source details

Source: dk-regnskabsdata-live-79091812-1793891373354

Document: dk-regnskabsdata-79091812-AZ9GF0WeLTLXsiSAXASp-1

XBRL: fsa:Revenue

Period: 01 Apr 2025 - 31 Mar 2026

Technical details

Context: D0

Unit: U-iso4217-DKK

Operating profit

DKK 41.4m

Latest period

Source details

Source: dk-regnskabsdata-live-79091812-1793891373354

Document: dk-regnskabsdata-79091812-AZ9GF0WeLTLXsiSAXASp-1

XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities

Period: 01 Apr 2025 - 31 Mar 2026

Technical details

Context: D0

Unit: U-iso4217-DKK

Net result

DKK 25.4m

Latest period

Source details

Source: dk-regnskabsdata-live-79091812-1793891373354

Document: dk-regnskabsdata-79091812-AZ9GF0WeLTLXsiSAXASp-1

XBRL: fsa:ProfitLoss

Period: 01 Apr 2025 - 31 Mar 2026

Technical details

Context: D0

Unit: U-iso4217-DKK

Equity

DKK 497m

Equity ratio: 37.1%

Source details

Source: dk-regnskabsdata-live-79091812-1793891373354

Document: dk-regnskabsdata-79091812-AZ9GF0WeLTLXsiSAXASp-1

XBRL: fsa:Equity

Period: 01 Apr 2025 - 31 Mar 2026

Technical details

Context: I3

Unit: U-iso4217-DKK

Development

Reported values. Missing periods appear as gaps.

Open full financials
RevenueNet result
Tabular view of development
YearRevenueNet result
2020DKK 3.7bnDKK 34.4m
2021DKK 3.7bnDKK 19.9m
2022DKK 3.8bnDKK 13.4m
2023DKK 4.2bnDKK 3.2m
2024DKK 4.2bnDKK 1.6m
2025DKK 4.1bnDKK -51k
2026DKK 4.4bnDKK 25.4m